{content}

Study list

Gras

Spain
|
2023-2023
  • Adults
  • Elderly
  • Fragile population
  • Hospital wide
  • Outpatient clinic
  • SARS-CoV-2
  • Acute SARS-CoV-2
  • Pharmacological intervention
  • Antivirals
  • Remdesivir

Mischke

Germany
|
2023
  • Adults
  • General population
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Rehabilitation
  • Neurostimulation

MULTI-COVID

Italy
|
2023-2023
  • Adults
  • Elderly
  • Primary care
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Rehabilitation

VERDIQual

United Kingdom Thailand Italy Nigeria
|
2023-2025
  • Adults
  • Monkeypox virus
  • Monkeypox virus infection

Drysdale

United Kingdom
|
2022-2022
  • Adults
  • Elderly
  • Fragile population
  • Primary care
  • SARS-CoV-2
  • Acute SARS-CoV-2
  • Pharmacological intervention
  • Antivirals
  • Nirmatrelvir/Ritonavir
  • Monoclonal antibodies
  • Sotrovimab
  • Molnupiravir

HemCOV

Sweden
|
2022-2037
  • Adults
  • General population
  • Community
  • SARS-CoV-2
  • Post-COVID-19

Meuris

Belgium
|
2022-2025
  • Adults
  • People at high risk of STIs
  • Men who have sex with men
  • Hospital wide
  • Outpatient clinic
  • Monkeypox virus
  • Monkeypox virus infection

PreVitaCOV

Germany
|
2022-2025
  • Adults
  • General population
  • Elderly
  • Primary care
  • SARS-CoV-2
  • Post-COVID-19
  • Pharmacological intervention
  • Immnunomodulator
  • Prednisolone
  • Vitamin B1
  • Vitamin B12
  • Vitamin B6

DELong#3

Italy
|
2022-2023
  • Adults
  • General population
  • Elderly
  • Outpatient clinic
  • SARS-CoV-2
  • Post-COVID-19
  • Pharmacological intervention
  • Probiotic

Aguareles

Spain
|
2022-2023
  • Adults
  • Elderly
  • Fragile population
  • Immunocompromised host
  • Hospital wide
  • SARS-CoV-2
  • Acute SARS-CoV-2
  • Pharmacological intervention
  • Antivirals
  • Plitidepsin

Armstrong

United Kingdom
|
2022-2023
  • Adults
  • General population
  • Elderly
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Lifestyle

ErgoLoCo

Germany
|
2022-2023
  • General population
  • Elderly
  • Adult
  • Primary care
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Rehabilitation